Japan is a land of opportunity for drug discovery and development technologies.  With annual sales of $40 billion, the Japanese pharmaceutical market is the second largest individual market (after the USA) in the world and is dominated by internal production from within Japan.   Japanese pharma export an additional $20 billion of products. 

We are actively looking for new service and research tool providers for partnering under the MediBIC umbrella and helping them succeed in the Japanese or Asian markets.

To our partnerships we bring in Japanese speaking technical expertise, familiarity with the Japanese pharma activities and their needs, and significant financial resources with dedicated marketing and sales staff.